Yüksel Ürün: A study from Sweden on over 350,000 men

Yüksel Ürün shared on X:

“A study from Sweden on over 350,000 men: .

•  α1-adrenoceptor antagonists do not increase mortality from prostate cancer nor the risk of high-grade prostate cancer.
• However, these drugs are linked to a slight increase in overall prostate cancer incidence, especially lower-grade types. Possible detection bias?
• These medications include alfuzosin, doxazosin, terazosin, tamsulosin, and prazosin. These medications are FDA-approved to treat benign prostatic hyperplasia (BPH).“

Source: Yüksel Ürün/X

Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey. His research focuses on genitourinary cancers, covering epidemiology, diagnosis, biomarkers, meta-analysis, and treatment outcomes.

His dedication to patient care and research inspires positive change in the medical field.